Ask Warren

Curiox Biosystems

445680 · KOSDAQ · ₩445680 · 큐리옥스바이오시스템즈

₩62,400▲ ₩100 (0.16%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y −7.42%
Market cap
₩1.1T
Enterprise value
₩1.1T
P/E
—
P/B
21.9×
Dividend yield
0.0%
ROE
−26.1%
Net margin
−222.9%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−58.2% from the high

₩31,650Today: ₩58,700 – ₩64,400₩149,200

Returns

  • 1W−1.3%
  • 1M+24.1%
  • 3M+81.9%
  • 6M−38.5%
  • YTD−46.7%
  • 1Y−7.4%
Volume today
117,133
0.6× the 20-day average
Traded today
₩7.3B
Listed shares
17,224,699
EPS (12 months)
−₩742
Earnings yield −1.2%
SellBuy
AI research · Update noteCuriox Biosystems: Shares Fall 15.3% in Five Days on Heavy Volume, No Filing Explains the MoveThe 15.3% drop on heavy volume narrows the gap between the share price and the reported financials, but it adds no fundamental information.Read the full report →

Upcoming dates

Full calendar →

🎁 Gift this stock

Send a friend ₩100,000 of paper money in this stock. They get it when they join.

XfWATGr/in@

Signals

38Quiet
  • BuzzQuietBuzz 38 of 100 (50 is a normal day for this stock).
  • SentimentNegativeNews: Headline reports a widening operating loss. Community: 0 bullish, 0 bearish posts this week.
  • MomentumStrong25.8% over the last month; the price is above its 20-day average.
  • News impactHigh4 news items and filings in two weeks; 1 rated high impact, 1 medium.

Signals describe activity, not recommendations. Not financial advice.

Leveraged ETF flows

Estimated leveraged-ETF rebalance on Oct 27: buy ₩342M at the close (3.1% of 20-day average trading value)

Sep 28Last 20 trading days (% of average trading value)Oct 27

On its 34 biggest days of the last 60 (moves of 3%+), the estimated pressure averaged 14.9% of trading value and pointed the same way 23 of 34 times.

  • 2× KODEX KOSDAQ150 Leverage ₩279M
  • 2× TIGER KOSDAQ150 Leverage ₩33M
  • -1× KODEX KOSDAQ150 Futures Inverse ₩19M
  • 2× RISE KOSDAQ150 Futures Leverage ₩5.8M
  • 2× KIWOOM KOSDAQ150 Futures Leverage ₩1.5M

Mostly via futures: index funds hedge with KOSPI 200 / KOSDAQ 150 futures, spread here over the index's largest members by market value.

Final after the close. An intraday "if the close were now" estimate needs real-time prices, which we don't have yet.

Estimate based on ETF size and daily moves; actual trades may differ.

ETFs holding this

All ETFs →

Held by 11 funds.

Estimated from the funds' index or underlying stock.

Curiox Biosystems stock overview

Curiox Biosystems (큐리옥스바이오시스템즈, KRX: 445680) is listed on KOSDAQ, in the Medical & precision devices sector. The company sells automated instruments and consumables for cell analysis workflows, aiming to standardize these processes globally. Its shares closed at ₩62,400 on Oct 28, 2026, up 0.16% on the day, giving it a market value of ₩1.1T.

Key facts

Market cap
₩1.1T
Sector
Medical & precision devices
Latest price change
+0.16%
As of
Oct 28, 2026
Main business
The company sells automated instruments and consumables for cell analysis workflows, aiming to standardize these processes globally.

Quick answers about Curiox Biosystems

What does Curiox Biosystems do?
The company sells automated instruments and consumables for cell analysis workflows, aiming to standardize these processes globally. Its core technology, Pluto Wash, washes cells by gravity instead of centrifugation to reduce cell damage and improve reproducibility, and is delivered as software (Pluto Code) that runs on widely used liquid handling workstations from several brands. Its products, including the Pluto workstations, Venus HT and Laminar Wash systems, mainly target life science researchers, diagnostics and bio-pharma customers, with its sales focus on flow cytometry.
What is the market cap of Curiox Biosystems?
The market capitalisation of Curiox Biosystems was ₩1.1T at the close on Oct 28, 2026.
Who are the largest shareholders of Curiox Biosystems?
According to the latest official filings, the largest reported holders are Kim Nam-yong (17.16%, as of Aug 10, 2026); ZIGVenturesLimited (4.64%, as of Oct 17, 2025); VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND (2.45%, as of Jul 31, 2026).
When is the next earnings report from Curiox Biosystems?
Korean companies rarely announce results dates in advance. Based on when Curiox Biosystems filed the same report in past years, its next 3q results is expected between Nov 10, 2026 and Nov 14, 2026.
Does the National Pension Service own Curiox Biosystems?
Yes. The National Pension Service held 1.25% of Curiox Biosystems shares as of Dec 31, 2023.

Company profile

The company sells automated instruments and consumables for cell analysis workflows, aiming to standardize these processes globally. Its core technology, Pluto Wash, washes cells by gravity instead of centrifugation to reduce cell damage and improve reproducibility, and is delivered as software (Pluto Code) that runs on widely used liquid handling workstations from several brands. Its products, including the Pluto workstations, Venus HT and Laminar Wash systems, mainly target life science researchers, diagnostics and bio-pharma customers, with its sales focus on flow cytometry.

Written by AI from the company's latest annual report.

Korean name
큐리옥스바이오시스템즈
Sector
Medical & precision devices
Themes
Biotech (new drugs)Medical devices
CEO
김남용
Founded
Sep 2018
Listed
Aug 2023
Listed shares
17,224,699
Fiscal year ends
Month 12
Website
curiox.co.kr/

Similar companies

Recent news

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: Curiox Biosystems / 큐리옥스바이오시스템즈 / 445680 / KRX:445680

Source: KRX statistical information